These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

345 related articles for article (PubMed ID: 3372263)

  • 1. Sequence analysis of HLA class II genes from insulin-dependent diabetic individuals.
    Horn GT; Bugawan TL; Long CM; Manos MM; Erlich HA
    Hum Immunol; 1988 Apr; 21(4):249-63. PubMed ID: 3372263
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A diabetes-susceptible HLA haplotype is best defined by a combination of HLA-DR and -DQ alleles.
    Sheehy MJ; Scharf SJ; Rowe JR; Neme de Gimenez MH; Meske LM; Erlich HA; Nepom BS
    J Clin Invest; 1989 Mar; 83(3):830-5. PubMed ID: 2784133
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transcomplementation of HLA DQA1-DQB1 in DR3/DR4 and DR3/DR9 heterozygotes and IDDM in Taiwanese families.
    Chuang LM; Wu HP; Tsai WY; Lin BJ; Tai TY
    Diabetes Care; 1995 Nov; 18(11):1483-6. PubMed ID: 8722074
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HLA-DQ beta sequence polymorphism and genetic susceptibility to IDDM.
    Erlich HA; Bugawan TL; Scharf S; Nepom GT; Tait B; Griffith RL
    Diabetes; 1990 Jan; 39(1):96-103. PubMed ID: 2210066
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A gene in the HLA class I region contributes to susceptibility to IDDM in the Finnish population. Childhood Diabetes in Finland (DiMe) Study Group.
    Fennessy M; Metcalfe K; Hitman GA; Niven M; Biro PA; Tuomilehto J; Tuomilehto-Wolf E
    Diabetologia; 1994 Sep; 37(9):937-44. PubMed ID: 7806025
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular studies of a rare DR2/LD-5a/DQw3 HLA class II haplotype. Multiple genetic mechanisms in the generation of polymorphic HLA class II genes.
    Liu CP; Bach FH; Wu SK
    J Immunol; 1988 May; 140(10):3631-9. PubMed ID: 3129499
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Analysis of HLA genotypes and susceptibility to insulin-dependent diabetes mellitus: HLA-DQ alpha complements HLA-DQ beta.
    Baisch JM; O'Brien ME; Hoover ML; Capra JD
    Scand J Immunol; 1992 Aug; 36(2):321-30. PubMed ID: 1502499
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Insulin-dependent diabetes mellitus in non-DR3/non-DR4 subjects.
    Dubois-Laforgue D; Timsit J; Djilali-Saiah I; Boitard C; Caillat-Zucman S
    Hum Immunol; 1997 Oct; 57(2):104-9. PubMed ID: 9438201
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HLA DQ beta 3.2 identifies subtypes of DR4+ haplotypes permissive for IDDM.
    Robinson DM; Holbeck S; Palmer J; Nepom GT
    Genet Epidemiol; 1989; 6(1):149-54. PubMed ID: 2567255
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Insulin-dependent diabetes mellitus: HLA-DR and -DQ genotyping in three ethnic groups.
    Kohonen-Corish MR; Serjeantson SW; Lee HK; Zimmet P
    Dis Markers; 1987 Sep; 5(3):153-64. PubMed ID: 2901933
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular cloning of a polymorphic DNA endonuclease fragment associates insulin-dependent diabetes mellitus with HLA-DQ.
    Michelsen B; Lernmark A
    J Clin Invest; 1987 Apr; 79(4):1144-52. PubMed ID: 2881947
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dose effect of cis- and trans-encoded HLA-DQ alpha beta heterodimers in IDDM susceptibility.
    Khalil I; Deschamps I; Lepage V; al-Daccak R; Degos L; Hors J
    Diabetes; 1992 Mar; 41(3):378-84. PubMed ID: 1551498
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Definition of IDDM-associated HLA DQ and DX RFLPs by segregation analysis of multiplex sibships.
    Carrier CM; Mollen N; Rothman WC; Rodriguez de Cordoba S; Rey-Campos J; Ginsberg-Fellner F; Carpenter C; Rubinstein P
    Hum Immunol; 1989 Jan; 24(1):51-63. PubMed ID: 2563360
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison between HLA-DRB and DQ DNA sequences and classic serological markers as type 1 (insulin-dependent) diabetes mellitus predictive risk markers in the Spanish population.
    Vicario JL; Martinez-Laso J; Corell A; Martin-Villa JM; Morales P; Lledo G; Segurado OG; de Juan D; Arnaiz-Villena A
    Diabetologia; 1992 May; 35(5):475-81. PubMed ID: 1355747
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Analysis of DR and DQ gene products of the DR4 haplotype in patients with IDDM: possible involvement of more than one locus.
    Monos DS; Mickelson E; Hansen JA; Baker L; Zmijewski CM; Kamoun M
    Hum Immunol; 1988 Dec; 23(4):289-99. PubMed ID: 3266208
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HLA haplotypes in type 1 (insulin-dependent) diabetes mellitus: molecular analysis of the HLA-DQ locus. The DIME Study Group.
    Tienari PJ; Tuomilehto-Wolf E; Tuomilehto J; Peltonen L
    Diabetologia; 1992 Mar; 35(3):254-60. PubMed ID: 1348711
    [TBL] [Abstract][Full Text] [Related]  

  • 17. T cell defined HLA epitopes and T cell receptor polymorphism in insulin dependent diabetes mellitus.
    Sheehy MJ
    Baillieres Clin Endocrinol Metab; 1991 Jun; 5(2):341-55. PubMed ID: 1716435
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sequence analysis of the HLA-DR beta and HLA-DQ beta loci from three Pemphigus vulgaris patients.
    Scharf SJ; Long CM; Erlich HA
    Hum Immunol; 1988 May; 22(1):61-9. PubMed ID: 3391803
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Different contribution of HLA-DR and -DQ genes in susceptibility and resistance to insulin-dependent diabetes mellitus (IDDM).
    Yasunaga S; Kimura A; Hamaguchi K; Ronningen KS; Sasazuki T
    Tissue Antigens; 1996 Jan; 47(1):37-48. PubMed ID: 8929711
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunogenetics of disease susceptibility: new perspectives in HLA.
    Nepom GT; Seyfried CA; Nepom BS
    Pathol Immunopathol Res; 1986; 5(1):37-46. PubMed ID: 3774753
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.